These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1546727)

  • 41. Risk of venous thromboembolism by route of administration of estrogen.
    Lobo RA
    Menopause; 2011 May; 18(5):469-70. PubMed ID: 21407136
    [No Abstract]   [Full Text] [Related]  

  • 42. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 43. Estrogen replacement therapy and breast cancer.
    Maguire PJ
    J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding breast density and breast cancer risk.
    Peres J
    J Natl Cancer Inst; 2012 Sep; 104(18):1345-6. PubMed ID: 22984197
    [No Abstract]   [Full Text] [Related]  

  • 47. [Vascular accidents of estrogen therapy for prostatic cancer metastases].
    Jurascheck F
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):400-2. PubMed ID: 4804405
    [No Abstract]   [Full Text] [Related]  

  • 48. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 50. Estrogen and C-reactive protein: does an alternate route lead to a more attractive destination?
    Duvernoy C
    Thromb Haemost; 2003 Jul; 90(1):1-2. PubMed ID: 12876618
    [No Abstract]   [Full Text] [Related]  

  • 51. Breast cancer risk and pretreatment estrogen levels.
    Pines A
    Climacteric; 2014 Feb; 17(1):103-4. PubMed ID: 24571033
    [No Abstract]   [Full Text] [Related]  

  • 52. Estrogen replacement therapy and the risk of venous thrombosis.
    Devor M; Barrett-Connor E; Renvall M; Feigal D; Ramsdell J
    Am J Med; 1992 Mar; 92(3):275-82. PubMed ID: 1546726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Coronary artery disease and menopausal hormone therapy].
    Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z; Holecki M
    Pol Arch Med Wewn; 2004 Oct; 112(4):1255-63. PubMed ID: 15773440
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 55. [P-pills, hormonal substitution and surgery--yes, or no?].
    Maltau JM; Oian P
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):934. PubMed ID: 7709380
    [No Abstract]   [Full Text] [Related]  

  • 56. Deep vein thrombosis in a transgender woman.
    Chan W; Drummond A; Kelly M
    CMAJ; 2017 Apr; 189(13):E502-E504. PubMed ID: 28385895
    [No Abstract]   [Full Text] [Related]  

  • 57. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 58. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormone replacement therapy and breast cancer: an overview.
    Theriault RL
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():87-90; discussion 90-1. PubMed ID: 8624349
    [No Abstract]   [Full Text] [Related]  

  • 60. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.